{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:38:51Z","timestamp":1759451931635,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":303,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.03.045","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T09:01:41Z","timestamp":1554195701000},"page":"2477-2481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants"],"prefix":"10.1016","volume":"37","author":[{"given":"H.","family":"Findlow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.O.","family":"Sow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.C.","family":"Haidara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Keita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Doumbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Traore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Schluterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.03.045_b0005","unstructured":"World Health Organization. Maternal and Neonatal Tetanus Elimination (MNTE); 2007. <http:\/\/www.who.int\/immunization\/diseases\/MNTE_initiative\/en\/>. [accessed 04 May 2018]."},{"key":"10.1016\/j.vaccine.2019.03.045_b0010","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/infdis\/jix629","article-title":"Protective effect of maternal influenza vaccination on influenza in their infants: a prospective cohort study","author":"Ohfuji","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.03.045_b0015","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.03.045_b0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/cid\/ciu821","article-title":"Case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012\u20132013","volume":"60","author":"Dabrera","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.03.045_b0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1590\/S1413-86702009000200006","article-title":"Ineffectiveness for infants of immunization of mothers with pneumococcal capsular polysaccharide vaccine during pregnancy","volume":"13","author":"Lopes","year":"2009","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.03.045_b0030","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S1473-3099(16)30054-8","article-title":"Maternal immunisation with trivalent inactivated influenza vaccine for prevention of influenza in infants in Mali: a prospective, active-controlled, observer-blind, randomised phase 4 trial","volume":"16","author":"Tapia","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.03.045_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/jcm.30.1.154-159.1992","article-title":"Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay","volume":"30","author":"Carlone","year":"1992","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.03.045_b0040","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/jcm.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2019.03.045_b0045","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/cdli.2.2.132-137.1995","article-title":"Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992","volume":"2","author":"Holder","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.03.045_b0050","first-page":"1","article-title":"assignment of Neisseria meningitidis serogroups A, C, W135 and Y anticapsular immunoglobulin G (IgG), IgG1 and IgG2 concentrations to reference sera","volume":"11","author":"Joseph","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.03.045_b0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM197709292971302","article-title":"Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age","volume":"297","author":"Peltola","year":"1977","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.03.045_b0060","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/cid\/civ551","article-title":"Introduction and rollout of a new group A meningococcal conjugate vaccine (PsA-TT) in African meningitis belt countries, 2010\u20132014","volume":"61","author":"Djingarey","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.03.045_b0065","doi-asserted-by":"crossref","first-page":"S594","DOI":"10.1093\/cid\/civ508","article-title":"Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt","volume":"61","author":"Karachaliou","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"43","key":"10.1016\/j.vaccine.2019.03.045_b0070","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2017.09.002","article-title":"Prevalence and decay of maternal pneumococcal and meningococcal antibodies: a meta-analysis of type-specific decay rates","volume":"35","author":"Voysey","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.045_b0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(95)91861-2","article-title":"Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine","volume":"346","author":"Shahid","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2019.03.045_b0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1128\/CVI.13.4.507-510.2006","article-title":"Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate Vaccine","volume":"13","author":"Findlow","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2019.03.045_b0085","doi-asserted-by":"crossref","first-page":"S563","DOI":"10.1093\/cid\/civ505","article-title":"Neisseria meningitidis group A IgG1 and IgG2 subclass immune response in African children aged 12\u201323 months following meningococcal vaccination","volume":"61","author":"Holme","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:26Z","timestamp":1759401086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19303792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19303792"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kinetics of maternally-derived serogroup A, C, Y and W-specific meningococcal immunoglobulin G in Malian women and infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}